Publications
Text queries can be conducted by Author, Title, or Keyword.
[18F]-fluorodeoxyglucose (FDG) and positron emission tomography
(PET) in aging and dementia. A decade of studies
Source: Eur Neurol 1989;29 Suppl 3:16-24.
Author: Hoffman JM;Guze BH;Baxter LR;Mazziotta JC;Phelps ME
PubMed ID: 2693102
Abstract:
Alzheimer's disease (AD) is becoming an increasingly important public health problem. The clinical diagnosis of AD continues to be problematic and costly. [18F]-fluorodeoxyglucose-position emission tomography (FDG-PET) can assist with the diagnosis of AD at an early stage. The utility of FDG-PET in AD may also be extremely useful in the future when objective physiologic monitoring of drug effects and therapy are required
Source: Eur Neurol 1989;29 Suppl 3:16-24.
Author: Hoffman JM;Guze BH;Baxter LR;Mazziotta JC;Phelps ME
PubMed ID: 2693102
Abstract:
Alzheimer's disease (AD) is becoming an increasingly important public health problem. The clinical diagnosis of AD continues to be problematic and costly. [18F]-fluorodeoxyglucose-position emission tomography (FDG-PET) can assist with the diagnosis of AD at an early stage. The utility of FDG-PET in AD may also be extremely useful in the future when objective physiologic monitoring of drug effects and therapy are required